Ibogaine is derived from a plant native to West Africa. It has been used to treat conditions such as post-traumatic stress disorder (PTSD), anxiety, and addiction in some countries.

The executive order directs the Department of Health and Human Services to allocate at least $50 million for states developing programs focused on psychedelic drugs. Advocacy groups have long pushed for more research into psychedelics for treating various mental health issues.

As of midday, it remains unclear how the federal government will facilitate further research into ibogaine. The FDA is reportedly taking steps to enable the first human trials of ibogaine within the United States.

Ibogaine continues to be classified as a Schedule I drug in the U.S., which complicates its availability and research potential. Nevertheless, a small study indicated that ibogaine could safely reduce PTSD symptoms in veterans when combined with intravenous magnesium.

At least 27 people have died after taking ibogaine, according to a 2023 report. This raises concerns about its safety despite its potential benefits. Trump acknowledged these risks during the signing event, jokingly asking, “Can I have some, please?”

The Trump administration’s initiative could open doors for federal funding aimed at further investigating ibogaine’s effectiveness. The implications of this executive order are significant for those involved in mental health advocacy.

Trump stated, “If these turn out to be as good as people are saying, it’s going to have a tremendous impact.” His comments reflect a growing interest in alternative therapies amid rising mental health crises across the nation.

Сообщение Ibogaine: Donald Trump Signs Executive Order on появились сначала на justrealnews.

In a critical development, Fulton County, Georgia, is seeking the return of ballots seized by the FBI during a controversial investigation. This legal challenge represents a significant moment for both the county and the FBI, as it unfolds amidst heightened scrutiny of the bureau’s practices.

On October 2023, the FBI’s actions came under the spotlight when the director acknowledged that the bureau purchases data to track Americans. This admission has raised alarms regarding the implications of such practices, particularly in light of the FBI’s coercive powers over citizens.

As the situation escalates, lawmakers have expressed deep concerns about the potential abuse of purchased data by the federal government. The FBI has utilized commercial location data in a national security pilot program, a move that has sparked debate about privacy rights and government oversight.

In response to growing concerns, President Biden issued an executive order in 2024 aimed at limiting the sale of bulk sensitive personal data. Additionally, the proposed Government Surveillance Reform Act seeks to require a warrant for the federal government to acquire sensitive data about Americans.

Senate Intelligence Committee Chair Tom Cotton weighed in on the matter, stating, “If any other person can buy it, and the FBI can buy it, and it helps them locate a depraved child molester or savage cartel leader, I would certainly hope the FBI is doing anything it can to keep Americans safe.” This statement underscores the complexities surrounding the FBI’s data acquisition practices.

Currently, the timeline for the court case regarding the 2020 ballots remains unspecified, leaving many questions unanswered. Details remain unconfirmed regarding the exact implications of the FBI’s data purchasing practices, which continue to evolve.

The unfolding events in Fulton County not only impact the local community but also set a precedent for how federal agencies interact with sensitive data and the rights of individuals. As the legal battle progresses, the stakes are high for all parties involved.

Сообщение FBI Faces Legal Challenge Over 2020 Ballots in Fulton County появились сначала на justrealnews.